GE HealthCare's True Definition DL, a deep learning-based CT image reconstruction tool, has received FDA 510(k) clearance.
Key Details
- 1True Definition DL is a deep learning CT image reconstruction solution from GE HealthCare.
- 2The AI tool increases image resolution without requiring workflow or protocol changes.
- 3It improves visualization of fine anatomical structures such as small airways and pulmonary nodules.
- 4Designed to avoid longer scan times and higher radiation doses typically needed for detailed images.
- 5Available for both field CT upgrades and new installations on the Revolution Apex and Revolution Vibe platforms.
- 6Adds to GE’s portfolio of cleared DL-based imaging solutions, including TrueFidelity DL and True Enhance DL.
Why It Matters
FDA clearance of True Definition DL may enhance the adoption of deep learning reconstruction in CT imaging, potentially leading to better diagnostic confidence and outcomes with greater efficiency. This underscores the expanding role of AI in everyday radiology workflows.
Source
Radiology Business
Related News
•AuntMinnie
AI Triage Tool Speeds Up ICH Head CT Turnaround in ED
AI-based triage for intracranial hemorrhage on head CT reduced emergency department report turnaround by 13 minutes.
•Cardiovascular Business
FDA Clears Elucid's AI-Driven FFR-CT Solution for Cardiac Imaging
Elucid's FFR-IQ, an AI-powered noninvasive FFR-CT tool, receives FDA clearance for clinical use.
•Radiology Business
FDA Approves SimBioSys AI Tool for Breast Cancer Risk via MRI
SimBioSys received FDA clearance for TumorSight Risk, an AI tool assessing breast cancer recurrence risk using MRI.